Payal Kohli, MD, FACC

Payal Kohli

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Grand Rounds(SIGNIFICANT), Amgen(MODEST), DocWire(SIGNIFICANT), GE/Skyword(SIGNIFICANT), American College of Cardiology(MODEST), 2nd MD(SIGNIFICANT), Medscape(MODEST), Boston Scientific(SIGNIFICANT), Healthline(SIGNIFICANT), GE Skyword(SIGNIFICANT), Viz.ai(SIGNIFICANT), Family heart(MODEST) SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Merck(SIGNIFICANT), Astra Zeneca(MODEST), ZOLL(MODEST), Clinical Options(SIGNIFICANT), Bristol-Myers Squibb Company(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Doximity(MODEST) OFFICER, DIRECTOR ETC: Cherry Creek Heart(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Doximity(MODEST) SALARY: Tegna Broadcasting(SIGNIFICANT), Tegna Central and other Tegna stations(SIGNIFICANT), 9News/Tegna(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT), Presbyetrian St. Luke’s(NONE), Rose Medical Center(NONE), Daily Blast Live(NONE), Novartis(SIGNIFICANT), The Medical Center of Aurora(NONE), Medscape Cardiology Consult Editor (MODEST), Agepha Pharma(MODEST), Transcend(MODEST), Medpage(MODEST)

View Full Disclosure